These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33322225)

  • 1. Herpes Simplex Virus Type 1 Clinical Isolates Respond to UL29-Targeted siRNA Swarm Treatment Independent of Their Acyclovir Sensitivity.
    Kalke K; Lehtinen J; Gnjatovic J; Lund LM; Nyman MC; Paavilainen H; Orpana J; Lasanen T; Frejborg F; Levanova AA; Vuorinen T; Poranen MM; Hukkanen V
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33322225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swarms of chemically modified antiviral siRNA targeting herpes simplex virus infection in human corneal epithelial cells.
    Kalke K; Lund LM; Nyman MC; Levanova AA; Urtti A; Poranen MM; Hukkanen V; Paavilainen H
    PLoS Pathog; 2022 Jul; 18(7):e1010688. PubMed ID: 35793357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of clinical pathogenic herpes simplex virus 1 strains with enzymatically created siRNA pools.
    Paavilainen H; Lehtinen J; Romanovskaya A; Nygårdas M; Bamford DH; Poranen MM; Hukkanen V
    J Med Virol; 2016 Dec; 88(12):2196-2205. PubMed ID: 27191509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated shRNA interference against HSV-1 replication in vitro.
    Song B; Liu X; Wang Q; Zhang R; Yang T; Han Z; Xu Y
    J Neurovirol; 2016 Dec; 22(6):799-807. PubMed ID: 27566181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatically synthesized 2'-fluoro-modified Dicer-substrate siRNA swarms against herpes simplex virus demonstrate enhanced antiviral efficacy and low cytotoxicity.
    Levanova AA; Kalke KM; Lund LM; Sipari N; Sadeghi M; Nyman MC; Paavilainen H; Hukkanen V; Poranen MM
    Antiviral Res; 2020 Oct; 182():104916. PubMed ID: 32798603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic testing of patient herpes simplex virus type 1 and 2 isolates for acyclovir resistance by a novel method based on real-time cell analysis.
    Caliaro O; Barbani MT; Klenja S; Morfin F; Frobert E; Gorgievski M; Steinlin-Schopfer J; Suter-Riniker F
    J Clin Virol; 2020 Apr; 125():104303. PubMed ID: 32163870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children.
    Wang Y; Wang Q; Zhu Q; Zhou R; Liu J; Peng T
    J Clin Virol; 2011 Oct; 52(2):107-12. PubMed ID: 21778105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the Likelihood of Acyclovir Resistance-Associated Mutations in the Thymidine Kinase Genes of Herpes Simplex Virus 1 and Varicella-Zoster Virus.
    Fujii H; Harada S; Yoshikawa T; Yamada S; Omura N; Shibamura M; Inagaki T; Kato H; Fukushi S; Saijo M
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing herpes simplex virus type 1 capsid protein encoding genes by siRNA: a promising antiviral therapeutic approach.
    Jin F; Li S; Zheng K; Zhuo C; Ma K; Chen M; Wang Q; Zhang P; Fan J; Ren Z; Wang Y
    PLoS One; 2014; 9(5):e96623. PubMed ID: 24794394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2.
    Strand M; Islam K; Edlund K; Oberg CT; Allard A; Bergström T; Mei YF; Elofsson M; Wadell G
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5735-43. PubMed ID: 22908173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
    Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
    Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical treatment of herpes simplex virus infection with enzymatically created siRNA swarm.
    Paavilainen H; Lehtinen J; Romanovskaya A; Nygårdas M; Bamford DH; Poranen MM; Hukkanen V
    Antivir Ther; 2017; 22(7):631-637. PubMed ID: 28287396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between sensitivity of viral thymidine kinase-associated acyclovir-resistant herpes simplex virus type 1 and virulence.
    Omura N; Fujii H; Yoshikawa T; Yamada S; Harada S; Inagaki T; Shibamura M; Takeyama H; Saijo M
    Virol J; 2017 Mar; 14(1):59. PubMed ID: 28320407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
    Sauerbrei A; Bohn K; Heim A; Hofmann J; Weissbrich B; Schnitzler P; Hoffmann D; Zell R; Jahn G; Wutzler P; Hamprecht K
    Antivir Ther; 2011; 16(8):1297-308. PubMed ID: 22155911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes.
    Schubert A; Gentner E; Bohn K; Schwarz M; Mertens T; Sauerbrei A
    Antiviral Res; 2014 Jul; 107():16-22. PubMed ID: 24747042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and genotypic characterization of induced acyclovir-resistant clinical isolates of herpes simplex virus type 1.
    Hussin A; Md Nor NS; Ibrahim N
    Antiviral Res; 2013 Nov; 100(2):306-13. PubMed ID: 24055837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cucumis melo pectin as potential candidate to control herpes simplex virus infection.
    Agostinho KF; Rechenchoski DZ; Faccin-Galhardi LC; de Sousa ALN; Cunha AP; Ricardo NMPS; Linhares REC; Nozawa C
    FEMS Microbiol Lett; 2021 Mar; 368(4):. PubMed ID: 33565598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Mechanism of Acyclovir Resistance in Herpes Simplex Virus 1, Which Has a UAG Stop Codon between the First and Second AUG Initiation Codons.
    Nguyen PHA; Yamada S; Shibamura M; Inagaki T; Fujii H; Harada S; Fukushi S; Mizuguchi M; Saijo M
    Jpn J Infect Dis; 2020 Nov; 73(6):447-451. PubMed ID: 32611982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypic detection of acyclovir-resistant HSV-1: characterization of 67 ACV-sensitive and 14 ACV-resistant viruses.
    Frobert E; Cortay JC; Ooka T; Najioullah F; Thouvenot D; Lina B; Morfin F
    Antiviral Res; 2008 Jul; 79(1):28-36. PubMed ID: 18336925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
    J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.